The AA/EPA ratio is an important health indicator that tells us about the balance of certain fats in our bodies, specifically omega-6 and omega-3 fatty acids. This balance is key for controlling inflammation and keeping our hearts healthy.
Understanding the AA/EPA ratio is more than just knowing about the fats we eat; it's about getting a deeper insight into our health and how to take better care of ourselves.
The Arachidonic Acid (AA) to Eicosapentaenoic Acid (EPA) ratio, often referred to as the AA/EPA ratio, is a critical biomarker that offers deep insights into the body's balance of key fatty acids. This ratio is much more than a simple measure of dietary intake; it is closely linked to a host of health outcomes and physiological processes.
Fatty acids, particularly AA and EPA, are not just energy sources but are pivotal to several critical functions in the human body.
Arachidonic Acid, an omega-6 fatty acid, is a key component in cellular signaling and the body's inflammatory responses. It serves as a precursor to various eicosanoids, which are crucial in the regulation of immune and inflammatory responses.
Eicosapentaenoic Acid, an omega-3 fatty acid, is renowned for its anti-inflammatory properties. EPA competes with AA for incorporation into cell membranes and in the synthesis of eicosanoids, highlighting the importance of their balance. This balance is essential, as a skewed ratio can lead to a pro-inflammatory state.
EPA is not common in the standard Western diet, although it is abundant in arachidonic acid. A skewed AA/EPA ratio can drive dietary recommendations for better health.
Eicosanoids are a diverse group of bioactive lipid mediators including prostaglandins, thromboxanes, and leukotrienes, synthesized from arachidonic acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).
Fatty acids are the backbone of eicosanoids, signaling molecules derived from polyunsaturated fatty acids that regulate various physiological processes in the body. Different fatty acids produce different eicosanoids with different characteristics, some more pro-inflammatory or anti-inflammatory than others.
Eicosanoids exert their effects locally and transiently, influencing inflammation, immune response, vascular tone, and platelet aggregation, among other functions. AA, predominantly found in omega-6 fatty acids, serves as the primary precursor for pro-inflammatory eicosanoids.
In contrast, EPA and DHA, omega-3 fatty acids, give rise to less inflammatory eicosanoids, thus contributing to the regulation of inflammatory processes and maintaining homeostasis within the body. The balance between omega-6 and omega-3 fatty acids in the diet influences the production of eicosanoids and subsequently impacts inflammation and overall health.
The AA/EPA ratio is a critical indicator of the body’s inflammatory state. A higher ratio is often indicative of a pro-inflammatory condition, whereas a lower ratio suggests an anti-inflammatory state.
EPA competes with AA for key enzymes in the eicosanoid production pathway, resulting in the formation of less inflammatory products. A higher AA:EPA ratio is indicative of chronic inflammation, as it correlates with higher inflammation levels that can drive cardiovascular disease.
Increasing this ratio through EPA intake has shown benefits in reducing cardiovascular risk, as EPA exerts anti-inflammatory, anti-aggregatory, and endothelial function effects, thus shifting the balance towards cardiovascular health. [1., 11.]
The measurement of the AA/EPA ratio is typically conducted through blood tests, most commonly through venipuncture. Fasting is typically recommended, but it is important to consult with the ordering provider to discuss testing requirements.
Different experts can recommend different levels regarding an ideal AA/EPA ratio. It is important to consult with the lab company used. One company reports a desirable AA/EPA ratio between 2.5:1 and 11:1, with higher results being correlated with poor cardiovascular health.
Various strategies, such as dietary modifications, lifestyle changes, and supplementation, can help in maintaining or achieving an optimal AA/EPA ratio.
Diet plays a pivotal role in managing the AA/EPA ratio. Since the body cannot produce omega-3 and omega-6 fatty acids, they must be obtained through food. Diets high in omega-6 fatty acids and low in omega-3s can lead to a higher AA/EPA ratio, thus fostering a pro-inflammatory state.
To balance this ratio, increasing the intake of omega-3 rich foods such as fatty fish (like salmon, mackerel, and sardines), flaxseeds, and walnuts is essential. [9.]
Reducing the intake of foods high in omega-6 fatty acids, such as certain vegetable oils and processed foods is also beneficial.
Supplementation can be an effective way to manage the AA/EPA ratio, especially for individuals who struggle to obtain sufficient omega-3s from their diet. [1.]
Fish oil supplements, which are rich in EPA and DHA (another essential omega-3 fatty acid), are commonly recommended. It's important to consider the quality of supplements and to choose those that are free from contaminants.
Krill oil and algal oil are other options, particularly for individuals seeking plant-based or more sustainable sources.
Additionally, consulting with a healthcare provider before starting any supplement regimen is crucial, as they can recommend appropriate dosages and ensure that supplements do not interact with existing medications or conditions.
Lifestyle factors including exercise, stress management, and smoking cessation can also influence the AA/EPA ratio. While regular physical activity has been shown to increase the AA/EPA ratio, likely due to cellular repair mechanisms, the many benefits of regular exercise on heart health are well-known. [2., 8.]
Stress management techniques such as meditation and mindfulness can have a positive impact on overall inflammation and, consequently, on this ratio. [5., 7.]
Avoiding smoking is another crucial aspect, as smoking can exacerbate inflammation and negatively affect fatty acid levels. [11.]
Integrating these lifestyle changes can complement dietary and supplementation strategies in managing the AA/EPA ratio effectively.
Alongside monitoring the AA/EPA ratio, assessing other related biomarkers can provide a more comprehensive view of an individual's health status, particularly concerning inflammation and cardiovascular risk.
The Omega-3 Index is a test that measures the percentage of EPA and DHA (docosahexaenoic acid) in red blood cell membranes. This index is a reliable indicator of an individual's omega-3 status and has been linked to the risk of heart disease. [4.]
A higher Omega-3 Index is associated with a reduced risk of sudden cardiac death and other adverse cardiovascular outcomes. By analyzing this alongside the AA/EPA ratio, healthcare providers can gain valuable insights into a patient’s fatty acid balance and cardiovascular health.
Another important biomarker to consider is the triglycerides to HDL (high-density lipoprotein) cholesterol ratio. This ratio is a marker of lipid metabolism and cardiovascular health, and an important example of the connection between blood sugar and lipid levels in cardiometabolic disorders. [6.]
High levels of triglycerides coupled with low levels of HDL cholesterol are linked to an increased risk of atherosclerosis and heart disease. [6.] This ratio can provide additional information on cardiovascular risk, especially when considered in conjunction with the AA/EPA ratio.
High Sensitivity C-Reactive Protein is a marker of inflammation in the body. High levels of hsCRP are associated with various conditions, including cardiovascular disease and inflammatory diseases.
By measuring hsCRP levels, healthcare providers can assess the level of systemic inflammation, which can be a crucial factor in understanding the implications of an imbalanced AA/EPA ratio. [3.]
Incorporating the management of the AA/EPA ratio into healthcare practices is a significant stride towards personalized medicine.
Healthcare providers play a pivotal role in managing the AA/EPA ratio. They are tasked with not only interpreting the results of AA/EPA tests but also with integrating these findings into a patient’s overall health plan.
This involves evaluating the ratio in the context of the patient’s current health status, medical history, and risk factors for diseases. Providers can offer tailored advice on diet, supplementation, and lifestyle modifications to optimize the AA/EPA ratio.
Furthermore, they can monitor the efficacy of these interventions through regular follow-ups and adjustments based on subsequent test results.
The AA/EPA ratio should not be viewed in isolation but rather as part of a broader health picture. A comprehensive approach involves correlating the AA/EPA ratio with other biomarkers and health indicators.
This holistic view allows healthcare providers to identify underlying health issues, such as a propensity for inflammation-related diseases, and to implement more effective, personalized treatment plans.
Understanding the interplay between the AA/EPA ratio and other health aspects is essential for addressing the root causes of health issues and promoting overall wellness.
The integration of the AA/EPA ratio into personalized medicine represents a significant advancement in healthcare. Personalized medicine is about tailoring healthcare to individual patients, considering their unique genetic makeup, lifestyle, and environmental factors.
By incorporating the AA/EPA ratio into this framework, healthcare providers can offer more precise and effective interventions. This approach can lead to better outcomes in the prevention and management of various conditions, particularly those related to inflammation and cardiovascular health.
The AA/EPA ratio, thus, becomes a crucial tool in the personalized medicine arsenal, aiding in the development of customized health strategies for individual patients.
Click here to compare testing options and order an AA/EPA ratio test.
[1.] Burns T, Maciejewski SR, Hamilton WR, Zheng M, Mooss AN, Hilleman DE. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio. Pharmacotherapy. 2007 May;27(5):633-8. doi: 10.1592/phco.27.5.633. PMID: 17461697.
[2.] Davinelli S, Corbi G, Righetti S, et al. Relationship Between Distance Run Per Week, Omega-3 Index, and Arachidonic Acid (AA)/Eicosapentaenoic Acid (EPA) Ratio: An Observational Retrospective Study in Non-elite Runners. Frontiers in Physiology. 2019;10. doi:https://doi.org/10.3389/fphys.2019.00487
[3.] Fonseca FA, Izar MC. High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities. Clinics (Sao Paulo). 2016 Apr;71(4):235-42. doi: 10.6061/clinics/2016(04)11. PMID: 27166776; PMCID: PMC4825196.
[4.] Harris WS. The omega-3 index: clinical utility for therapeutic intervention. Curr Cardiol Rep. 2010 Nov;12(6):503-8. doi: 10.1007/s11886-010-0141-6. PMID: 20809235.
[5.] Jae SY, Heffernan KS, Yoon ES, et al. Pulsatile Stress, Inflammation and Change in Arterial Stiffness. Journal of Atherosclerosis and Thrombosis. 2012;19(11):1035-1042. doi:https://doi.org/10.5551/jat.13516
[6.] Kosmas CE, Rodriguez Polanco S, Bousvarou MD, Papakonstantinou EJ, Peña Genao E, Guzman E, Kostara CE. The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease. Diagnostics (Basel). 2023 Mar 1;13(5):929. doi: 10.3390/diagnostics13050929. PMID: 36900073; PMCID: PMC10001260.
[7.] Liu YZ, Wang YX, Jiang CL. Inflammation: The Common Pathway of Stress-Related Diseases. Front Hum Neurosci. 2017 Jun 20;11:316. doi: 10.3389/fnhum.2017.00316. PMID: 28676747; PMCID: PMC5476783.
[8.] Myers J. Exercise and Cardiovascular Health. Circulation. 2003;107(1). doi:https://doi.org/10.1161/01.cir.0000048890.59383.8d
[9.] National Institute of Health. Office of Dietary Supplements - Omega-3 Fatty Acids. Nih.gov. Published February 15, 2023. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
[10.] Nelson JR, Raskin S. The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease. Postgraduate Medicine. 2019;131(4):268-277. doi:https://doi.org/10.1080/00325481.2019.1607414
[11.] Okada K, Kotani K, Yagyu H, Ishibashi S. Eicosapentaenoic acid/arachidonic acid ratio and smoking status in elderly patients with type 2 diabetes mellitus. Diabetol Metab Syndr. 2014 Aug 13;6(1):85. doi: 10.1186/1758-5996-6-85. PMID: 25143787; PMCID: PMC4138366.
[12.] Sherratt SCR, Libby P, Bhatt DL, Mason P. Eicosapentaenoic acid (EPA) treatment increased the ratio to arachidonic (EPA/AA) and reduced adhesion molecule expression in vascular endothelium during inflammation. European journal of preventive cardiology (Print). 2023;30(Supplement_1). doi:https://doi.org/10.1093/eurjpc/zwad125.177